Canaccord Genuity Group Inc. (FRA:C6U)

Germany flag Germany · Delayed Price · Currency is EUR
7.95
-0.10 (-1.24%)
Last updated: Jun 3, 2026, 5:00 PM CET
Market Cap826.49M +37.4%
Revenue (ttm)1.21B +22.7%
Net Income-134.60M
EPS-1.37
Shares Out n/a
PE Ration/a
Forward PEn/a
Dividend0.21 (2.63%)
Ex-Dividend DateFeb 27, 2026
Volumen/a
Open8.05
Previous Close8.05
Day's Range7.95 - 8.05
52-Week Range5.65 - 8.55
Betan/a
Analystsn/a
Price Targetn/a
Earnings DateJun 3, 2026

About Canaccord Genuity Group

Canaccord Genuity Group Inc. operates as a full-service investment dealer in Canada, the United States, the United Kingdom, Europe, Crown Dependencies, and Australia. It operates through three segments: Canaccord Genuity Capital Markets, Canaccord Genuity Wealth Management, and Other. The Canaccord Genuity Capital Markets segment offers investment banking, advisory, research, and trading services for corporate, institutional, and government clients. Its Canaccord Genuity Wealth Management segment provides brokerage services and investment advic... [Read more]

Industry Security Brokers, Dealers, and Flotation Companies
Founded 1950
Employees 3,006
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol C6U

Financial Performance

In fiscal year 2025, Canaccord Genuity Group's revenue was 1.64 billion, an increase of 18.10% compared to the previous year's 1.39 billion. Losses were -28.91 million, 17.6% more than in 2024.

Financial numbers in CAD Financial Statements

News

Doubleview Gold Corp. Appoints Canaccord Genuity for Strategic Review

Doubleview Gold Corp. Appoints Canaccord Genuity for Strategic Review

1 day ago - GuruFocus

Canaccord Genuity flies into ASX hopeful Innovaero; NDR afoot

The West Australian developer of one-way attack drones hosted a non-deal roadshow last week.

16 days ago - The Australian Financial Review

Uranium play Peninsula Energy in $40m cash call

Canaccord Genuity and Shaw and Partners were offering new shares at 35¢ apiece, a roughly 10 per cent discount to the last close, on Thursday morning.

20 days ago - The Australian Financial Review

Anticipation builds for SpaceX and OpenAI IPOs

Chris Kerlow, senior portfolio manager at Canaccord Genuity, joins BNN Bloomberg to discuss investment strategy amid geopolitics.

21 days ago - BNN Bloomberg

QuantumCore to Present at Canaccord Genuity Virtual Quantum Symposium

Toronto, Ontario--(Newsfile Corp. - May 4, 2026) - QuantumCore Ltd. (CSE: QNCR) ("QuantumCore" or the "Company"), a developer of advanced quantum infrastructure technologies, today announced its parti...

4 weeks ago - Newsfile Corp

Imricor Medical Systems launches $60m capital raising

Canaccord Genuity, Morgans Financial and Taylor Collison are joint lead managers on the raising.

4 weeks ago - The Australian Financial Review

BLUENERGIES ANNOUNCES FINANCIAL ADVISORY AGREEMENTS WITH HAYWOOD SECURITIES INC. AND CANACCORD GENUITY CORP.

TSXV: BLU | OTCQX: BLUGF VANCOUVER, BC, April 16, 2026 /PRNewswire/ - BluEnergies Ltd. (TSXV: BLU) ("BLU" or the "Company") announces it has entered into new strategic advisory services agreements (th...

6 weeks ago - PRNewsWire

Canaccord Genuity announces $80M settlement with U.S. agencies

Canaccord Genuity (CCORF) announced that its U.S. broker-dealer subsidiary has entered into final settlement agreements with the Securities and Exchange Commission, the Financial Industry Regulatory A...

3 months ago - TheFly

Canaccord Genuity price target raised to C$16 from C$14 at TD Securities

TD Securities analyst Graham Ryding raised the firm’s price target on Canaccord Genuity (CCORF) to C$16 from C$14 and keeps a Buy rating on the shares.

3 months ago - TheFly

Canaccord Genuity Group Earnings Call Transcript: Q3 2026

Firm-wide revenue surged 37% year-over-year to CAD 616 million, with record client assets and strong growth in both Wealth Management and Capital Markets. Strategic acquisitions and cost efficiencies drove a 103% increase in pre-tax net income, while regulatory and market risks remain.

3 months ago - Transcripts

Canaccord Genuity Group Earnings release: Q3 2026

Canaccord Genuity Group released its Q3 2026 earnings on February 17, 2026, summarizing the period's financial results.

3 months ago - Filings

Canaccord Genuity Group Slides: Q3 2026

Canaccord Genuity Group has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on February 17, 2026.

3 months ago - Filings

CANACCORD GENUITY GROUP INC. BOLSTERS ITS CAPITAL MARKETS ADVISORY CAPABILITY WITH ACQUISITION OF LEADING ADVISOR TO THE RENEWABLE ENERGY SECTOR

TORONTO, Jan. 14, 2026 /PRNewswire/ - Canaccord Genuity Group Inc. (TSX: CF) (the "Company" or "Canaccord Genuity") is pleased to announce that through its U.S. capital markets business it has acquire...

5 months ago - PRNewsWire

Canaccord Genuity price target raised to C$14 from C$12 at TD Securities

TD Securities analyst Graham Ryding raised the firm’s price target on Canaccord Genuity (CCORF) to C$14 from C$12 and keeps a Buy rating on the shares.

7 months ago - TheFly

Canaccord Genuity Group Earnings Call Transcript: Q2 2026

Revenue surged 24% year-over-year to CAD 530 million, driven by strong wealth management and capital markets, but results were impacted by a large U.S. regulatory provision and a CAD 110 million goodwill impairment. Despite an IFRS loss, core operations and growth outlook remain robust.

7 months ago - Transcripts

Canaccord Genuity Group Earnings release: Q2 2026

Canaccord Genuity Group released its Q2 2026 earnings on November 14, 2025, summarizing the period's financial results.

7 months ago - Filings

Canaccord Genuity Group Slides: Q2 2026

Canaccord Genuity Group has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on November 14, 2025.

7 months ago - Filings

EBR Systems to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

SUNNYVALE, Calif.--(BUSINESS WIRE)--EBR Systems, Inc., developer of the world's only left ventricular wireless cardiac pacing device for heart failure, today announced that management will be particip...

7 months ago - Business Wire

Octave Bioscience to Participate in Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

MENLO PARK, Calif.--(BUSINESS WIRE)--Octave Bioscience, Inc., a leading precision care company that is delivering a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseas...

7 months ago - Business Wire

Canaccord confirms strategic review of British wealth unit, says no deal assured

Canaccord Genuity said on Friday it is evaluating options for its British wealth management business and had met with potential counterparties.

8 months ago - Reuters

Exclusive: Canaccord Genuity in early talks over possible sale of British wealth arm, sources say

Canadian financial services group Canaccord Genuity has been sounding out potential bidders, including CVC and Advent, for its British wealth arm, two people with knowledge of the matter told Reuters.

8 months ago - Reuters

TD Securities upgrades Canaccord Genuity on constructive wealth business view

As previously reported, TD Securities analyst Graham Ryding upgraded Canaccord Genuity (CCORF) to Buy from Hold with a price target of C$12, up from C$10, citing a more constructive view…

10 months ago - TheFly

Canaccord Genuity upgraded to Buy from Hold at TD Securities

TD Securities analyst Graham Ryding upgraded Canaccord Genuity (CCORF) to Buy from Hold with a price target of C$12, up from C$10.

10 months ago - TheFly

Canaccord Genuity Group Transcript: AGM 2025

The meeting saw all motions passed, including director elections and auditor appointment. Strong financial results were reported, with record revenue in wealth management and capital markets, while strategic acquisitions and cost efficiency initiatives were highlighted for future growth.

10 months ago - Transcripts

Canaccord Genuity Group Earnings Call Transcript: Q1 2026

Revenue rose 5% year-over-year to CAD 448 million, led by record wealth management results in the U.K. and Australia, while capital markets faced headwinds from policy uncertainty and lower advisory revenue. Positive net flows and expanding fee-based assets drove record client assets, and the outlook anticipates margin improvement and stronger M&A activity.

10 months ago - Transcripts